Pfizer’s drivers of strategy, growth and innovation to business development in Asia

Learn from Pfizer the growth potential of Asia, and explore the drivers of strategy, growth and innovation to enable business development, fro m Dr. Steven Adams, Head of Asia R&D Business Development,Pfizer, USA.

Dr. Adams has more than 15 years of experience in pre-clinical and clinical development, having worked in a variety of companies ranging to Biotech start-ups to Pharmas. In his current role as Head of Asia R&D Business Development in Pfizer, he is responsible for providing leadership to the Asia R&D business development team, which delivers a business development platform that enables access to research capability, science and technology across the Asia Pacific Region for Pfizer’s Research units.

At the BioPharma Asia 2011, Dr. Adams shared his views on profiting from the growth of Asia’s healthcare sector, and how healthcare companies are developing their business in this region. In addition, he spoke on the strategies and challenges in commercializing innovation or new business ideas. Lastly, he gave an analysis of the pharmaceutical industry and current M&A trends and gave a talk on the Pfizer story.

To learn more on his drivers of strategy, growth and innovation to drive business development in Asia, get a copy of the presentation slides that was presented by Dr. Steven Adams, Head of Asia R&D Business Development,Pfizer, USA, right here now!

Join us at BioPharma Asia Convention 2012! Contact us for more details now to be entitled to the early bird promotion!